DD289467A5 - Verbindungen zur behandlung von harninkontinenz - Google Patents

Verbindungen zur behandlung von harninkontinenz Download PDF

Info

Publication number
DD289467A5
DD289467A5 DD89334233A DD33423389A DD289467A5 DD 289467 A5 DD289467 A5 DD 289467A5 DD 89334233 A DD89334233 A DD 89334233A DD 33423389 A DD33423389 A DD 33423389A DD 289467 A5 DD289467 A5 DD 289467A5
Authority
DD
German Democratic Republic
Prior art keywords
methyl
diphenylacetamide
compound
general formula
compounds
Prior art date
Application number
DD89334233A
Other languages
German (de)
English (en)
Inventor
Bengst Ch H Sjoegren
Henri R Mollberg
Sten St Kelfve
Bertil V Hansen
Original Assignee
������@������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@������������k�� filed Critical ������@������������k��
Publication of DD289467A5 publication Critical patent/DD289467A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/40—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Underground Structures, Protecting, Testing And Restoring Foundations (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Dowels (AREA)
  • Table Equipment (AREA)
  • Finger-Pressure Massage (AREA)
  • Medicinal Preparation (AREA)
  • Discharge Heating (AREA)
DD89334233A 1988-11-04 1989-11-03 Verbindungen zur behandlung von harninkontinenz DD289467A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8804003A SE8804003D0 (sv) 1988-11-04 1988-11-04 Compounds for the treatment of urinary incontinence

Publications (1)

Publication Number Publication Date
DD289467A5 true DD289467A5 (de) 1991-05-02

Family

ID=20373858

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89334233A DD289467A5 (de) 1988-11-04 1989-11-03 Verbindungen zur behandlung von harninkontinenz

Country Status (22)

Country Link
EP (1) EP0367040B1 (da)
JP (1) JPH02218652A (da)
KR (1) KR900007407A (da)
CN (1) CN1043700A (da)
AT (1) ATE88460T1 (da)
AU (1) AU628879B2 (da)
CA (1) CA2001641A1 (da)
DD (1) DD289467A5 (da)
DE (1) DE68906122T2 (da)
DK (1) DK544689A (da)
ES (1) ES2054980T3 (da)
FI (1) FI895229A7 (da)
HU (1) HU202828B (da)
IE (1) IE63480B1 (da)
NO (1) NO894384L (da)
NZ (1) NZ231243A (da)
PH (1) PH27014A (da)
PT (1) PT92189B (da)
RU (1) RU1833370C (da)
SE (1) SE8804003D0 (da)
TW (1) TW197944B (da)
ZA (1) ZA898385B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066680A (en) * 1989-02-14 1991-11-19 Fujisawa Pharmaceutical Co., Ltd. Novel substituted-acetamide compound and a process for the preparation thereof
US5192779A (en) * 1989-02-14 1993-03-09 Fujisawa Pharmaceutical Co., Ltd. Substituted-acetamide compound and a process for the preparation thereof
ZA921292B (en) * 1991-02-25 1993-08-23 Lilly Co Eli Treatment of lower urinary tract disorders.
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
TW281667B (da) * 1994-02-03 1996-07-21 Synthelabo
GB0328060D0 (en) * 2003-12-04 2004-01-07 Sod Conseils Rech Applic Botulinum toxin treatment
MX379822B (es) 2015-04-28 2025-03-11 Unilever Ip Holdings B V Compuestos de n-aralquilcarbonil-piperazina y -homopiperazina y composciones para el cuidado personal que comprenden los mismos.
WO2016173818A1 (en) * 2015-04-28 2016-11-03 Unilever Plc N-aralkylcarbonyldiamine compounds and personal care compositions comprising the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2009144A (en) * 1935-07-23 Substituted amides of amphatic-
US2831892A (en) * 1956-03-22 1958-04-22 Searle & Co N-(3-isopropylaminopropyl) diphenyl-acetamide and processes
FR2319337A1 (fr) * 1975-07-30 1977-02-25 Fabre Sa Pierre Gem diaryles possedant une activite antiarythmique utile en therapeutique cardiovasculaire
FR2333501A2 (fr) * 1975-12-03 1977-07-01 Science Union & Cie Nouveaux acetamides substitues leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2340724A2 (fr) * 1976-02-13 1977-09-09 Science Union & Cie Nouveaux diarylacetamides substitues, leurs procedes de preparation et les compositions pharmaceutiques en contenant
FR2421891A1 (fr) * 1977-10-17 1979-11-02 Fabre Sa Pierre Obtention industrielle d'amides de la pyrrolidine ethyl amine
FR2421892A1 (fr) * 1977-10-17 1979-11-02 Fabre Sa Pierre Procede de synthese industrielle du n(n' ethyl pyrrolidino-2 methyl) aadiphenylahydroxy acetamide
US5066680A (en) * 1989-02-14 1991-11-19 Fujisawa Pharmaceutical Co., Ltd. Novel substituted-acetamide compound and a process for the preparation thereof

Also Published As

Publication number Publication date
TW197944B (da) 1993-01-11
AU4439489A (en) 1990-05-10
EP0367040B1 (en) 1993-04-21
DE68906122T2 (de) 1997-05-22
SE8804003D0 (sv) 1988-11-04
KR900007407A (ko) 1990-06-01
DK544689A (da) 1990-05-05
ZA898385B (en) 1990-07-25
IE63480B1 (en) 1995-05-03
PT92189B (pt) 1995-07-18
FI895229A0 (fi) 1989-11-03
PT92189A (pt) 1990-05-31
NO894384D0 (no) 1989-11-03
FI895229A7 (fi) 1990-05-05
IE893398L (en) 1990-05-04
DK544689D0 (da) 1989-11-01
HU895648D0 (en) 1990-01-28
DE68906122D1 (de) 1993-05-27
PH27014A (en) 1993-02-01
CN1043700A (zh) 1990-07-11
ATE88460T1 (de) 1993-05-15
RU1833370C (en) 1993-08-07
HU202828B (en) 1991-04-29
HUT51597A (en) 1990-05-28
CA2001641A1 (en) 1990-05-04
EP0367040A1 (en) 1990-05-09
NZ231243A (en) 1994-03-25
NO894384L (no) 1990-05-07
ES2054980T3 (es) 1994-08-16
AU628879B2 (en) 1992-09-24
JPH02218652A (ja) 1990-08-31

Similar Documents

Publication Publication Date Title
DE69429524T2 (de) Aminocyclohexylester und ihre anwendung
EP0400011B1 (de) Neue phenylethanolamine
EP0004952B1 (de) Spiro-(dihydrobenzofuranpiperidine und -pyrrolidine) und deren Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung für Arzneimittel
DD202001A5 (de) Verfahren zur herstellung von aminoaethanolen
US4782071A (en) Tetrasubstituted urea cholinergic agents
CH667657A5 (de) Carbocyclische und heterocyclische carbonylmethylen- und methylpiperidine und -pyrrolidine.
US4797419A (en) Method of treating the symptoms of senile cognitive decline employing di- or trisubstituted urea cholinergic agents
AT399338B (de) Neue substituierte benzamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese benzamide enthalten
DD155991A5 (de) Verfahren zur herstellung von imidazolin-derivaten
EP0739892A2 (de) Chromon-Derivate
US5236956A (en) Compounds for the treatment of urinary incontinence
DE68906122T2 (de) Verbindungen zur Behandlung von Harninkontinenz.
DE60025270T2 (de) N-substituierte benzyl oder phenyl arylsulfamide und ihre verwendung
US3998843A (en) Quaternary ammonium compounds
US4822778A (en) Membrane stabilizing phenoxy-piperidine compounds and pharmaceutical compositions employing such compounds
DE3133768A1 (de) N-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamid, verfahren zu seiner herstellung und es enthaltende pharmazeutisch vertraegliche arzneimittel
DD148633A5 (de) Verfahren zur herstellung von hexahydro-1,4-oxazepinen
DE2513136B2 (de) N-(I -Benzylpiperid-4-yl)-benzamide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
DE2654888A1 (de) Diphenylacetamide, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2754148A1 (de) Substituierte aminoaethanole, verfahren zu ihrer herstellung und ihre verwendung als arzneistoffe
RU2712638C1 (ru) N-(2-(2-(диалкиламино)этокси)этил)карбоксамиды и их гидрохлориды, обладающие антиаритмической активностью, и фармацевтические композиции на их основе
DE69714758T2 (de) Substitierte oxime, hydrazone und olefine als neurokinin antagonisten
DE4344648A1 (de) Neue Aminocarbonsäureamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2125892B2 (de) 23-Dihydro-5-trifluormethyl-lH- dibenzo [23 zu 6,7] thiepine [43] pyrrole, Verfahren zu ihrer Herstellung und diese enthaltende therapeutsche Präparate
AT376981B (de) Verfahren zur herstellung neuer pyrido-(1,2-a) pyrimidin-derivate, von deren pharmazeutisch akzeptablen salzen sowie deren solvaten, stereoisomeren und tautomeren

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee